FDA Investigator Jay T Wong

Jay T Wong has conducted inspections on 41 sites in 6 countries as of 07 Oct 2020. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
41
Last Inspection Date:
07 Oct 2020
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Germany, Canada, Denmark, Finland, China
FDA Investigators that have inspected at least one site in common with Jay T Wong:
Addam S Reynolds, Alan P Kurtzberg, Alice S Tsao, Amatul H Marium, Amy Chen, Amy Kim, Amy N Chen, Andrew M Abramowitz, Ann M Stewart, Anna Lazar, Anthony J Donato, Anthony Kovalenko, Arduino Frankovic, Armia A Beshay, Arsen Karapetyan, Barbara J Maulfair, Betty M Ng Lee, Bijoy Panicker, Bo Chi, PhD, Brandy N Lepage, Bruce G Cooper, Candace Y Gomez Broughton, Carla J Lundi, CDR Ileana Barreto Pettit, Charanjeet Jassal, Charisse K Green, Christian Parra, Christopher S Fields, Claire M Minden, Daniel L Zheng, Danna E Solorzano, David A Oluwo, David R Delucia, Dennis Cantellops Paite, Diane E Bruce, Donald L Lech, Dongping Dai, PhD, Douglas C Kovacs, Douglas G Ng, Dr. Robert C Horan, MD, Dr. Willie Wilson, PhD, Edouard Viard, Emest F Bizjak, Emily J Schramm, Eric Rothschild, Eufemia G Gonzalez, Feiyan Jin, Felix Maldonado, Frank Verni, Freddy Ortiz Colon, Frederick F Razzaghi, Gam S Zamil, Gary J Lehr, Gary T Greco, Guerlain Ulysse, Gwyn G Dickinson, Helen B Ricalde, Helen Verdel, Iram R Hassan, PhD, Irina Gaberman, J Paul Kirwan, PhD, Jacqueline Mdiaz Albertini, Jacqueline S Warner, Jaison J Eapen, James A Liubicich, James C Maclaughlin, James D Bridges, Jane C Chen, Jawaid Hamid, Jay B Shah, Jens Fricke, Jessica L Pressley, Joanne M Schlossin, John W Banks, José E Meléndez, Jose M Cayuela, Jose Ohernandez Guzman, Joy P Matthias, Juan Rjimenez Garcia, Juanita P Versace, Justin A Boyd, Kalavati Suvarna, PhD, Karen A Briggs, Karen L Kosar, Kathleen M Sinninger, Kathryn A Nagy, Kenneth G Klobus, Kevin A Gonzalez, Kimberley A Ricketts, Kristen D Evans, Kristina L Conroy, Kristy A Zielny, Kwong P Lee, Lakshmi Narasimhan, PhD, Laura Fontan, MS, Lawrence W Farina, LCDR Chad N Thompson, Lcr Jayt Wong, Liming Zhang, Lisa Shin, LTJG Matthew R Palo, Luella J Rossi, Luis A Dasta, Marea K Harmon, Margaret E Sarles, Margaret M Sands, Maria Joselopez Barragan, PhD, Marie B Buen Bigornia, Maxwell Van Tassell, PhD, Melinee C Minhas, Meredith L Sheridan, Meredith P Soehl, Investigator, Michael A Charles, Michael Levin, Michael R Goga, Michael R Klapal, Michelle Yclark Stuart, Milos Dokmanovic, PhD, Mindy M Chou, Miral B Patel, Monika Borkowska, Mra Davism, Nancy F Scheraga, Nancy M Espinal, Nariman Patenaude, Nazmul Hassan, Neil J Bonzagni, PhD MPH, Nicholas A Violand, Nicholas L Paulin, Nikki S Ramirez, Ogechi C Nna, Omadevi Somai, Investigator, Omotunde O Osunsanmi, Parul M Patel, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Patrick L Wisor, Paul L Bellamy, Paul Mouris, Peter Abel, Peter M Trunk, Peter R Caparelli, Peter S Diak, Rachael A Moliver, Rachael O Oyewole, Rajiv R Srivastava, Reyes Candau Chacon, PhD, Richard Ledwidge (nmi), PhD, Robert C Steyert, Robert J Martin, Roger F Zabinski, Rose Xu, Roy R Rinc, Russell J Glapion, Samina S Khan, Sarah Kennett, PhD, Sasha M Latonis, Satheesh Thomas, Sena G Dissmeyer, Shari L Kahn, Sherry G Bous, Sinai I Davis, Sony Mathews, Srinivas R Chennamaneni, PhD, Steven J Libal, Stuart W Russell, Susan M Jackson, Susan W Ting, Suwaskie S Smith, Syeda N Mahazabin, Taichun Qin, PhD, Tanya R Syffrard, Tara K Carmody, Tara K Normandin, Tekalign Wondimu, Thomas J Mooney, Thuy T Nguyen, LCDR, Toyin B Oladimeji, Tracy M Portelli, Truong Xuan Nguyen (Andy), Tyanna N Hadley, Tzanko Stantchev, Uduak M Inokon, Vincent T Duncan, Vivin George, Walden H Lee, Wayne E Seifert, Yumi J Hiramine, Yvesna C Blaise, Zhongren Wu

Jay T Wong's Documents

Publish Date Document Type Title
February, 2019 EIR Chartwell Pharmaceuticals Amityville, LLC. - EIR, 2019-02-13
December, 2017 FDA 483 POLYGEN PHARMACEUTICALS INC. - Form 483, 2017-12-18
May, 2017 FDA 483 Amneal Pharmaceuticals of New York, LLC - Form 483, 2017-05-24
December, 2019 EIR TIME CAP LABORATORIES, INC - EIR, 2019-12-18
January, 2018 EIR Veranova, L.P. - EIR, 2018-01-31
April, 2019 FDA 483 ImprimisRx NJ - Form 483, 2019-04-09
May, 2018 FDA 483 MANA PRODUCTS, INC. - Form 483, 2018-05-11
June, 2017 FDA 483 Bentley Laboratories, LLC - Form 483, 2017-06-09
October, 2020 FDA 483 Syntec Pharma Corp. - Form 483, 2020-10-28
August, 2019 FDA 483 Zhejiang Starry Pharmaceutical Co., Ltd - Form 483, 2019-08-02
December, 2019 FDA 483 TIME CAP LABORATORIES, INC - Form 483, 2019-12-18
November, 2018 FDA 483 GRAXCELL USA, LLC - Form 483, 2018-11-05
February, 2019 FDA 483 Chartwell Pharmaceuticals Amityville, LLC. - Form 483, 2019-02-13
May, 2019 FDA 483 Evaric Pharmaceuticals Inc - Form 483, 2019-05-29
February, 2018 EIR Ascent Pharmaceuticals Inc - EIR, 2018-02-21
January, 2019 FDA 483 SSG Ventures - Form 483, 2019-01-02
June, 2017 EIR Bentley Laboratories, LLC - EIR, 2017-06-09
January, 2016 FDA 483 Topiderm, Inc. - Form 483, 2016-01-21
June, 2018 EIR Regeneron Pharmaceuticals, Inc. - EIR, 2018-06-08
March, 2017 FDA 483 Jerome Stevens Pharmaceuticals, Inc. - Form 483, 2017-03-30
August, 2019 FDA 483 Hubei Biocause Heilen Pharmaceutical Co., Ltd - Form 483, 2019-08-16
January, 2018 FDA 483 Veranova, L.P. - Form 483, 2018-01-31
June, 2018 FDA 483 XGen Pharmaceuticals DJB, Inc. - Form 483, 2018-06-22
November, 2017 FDA 483 A&Z Pharmaceutical, Inc. - Form 483, 2017-11-22
January, 2018 FDA 483 Response Veranova, L.P. - Form 483R, 2018-02-21

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more